Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02995759 · ClinicalTrials.gov registry record

Creation, Implementation, and Analysis of a Seizure Action Plan

A clinical trial, sponsored by Boston Children's Hospital.

Completed
Registry status
288
Enrollment target

NCT02995759: Completed study, sponsored by Boston Children's Hospital.

NCT02995759 is a clinical trial that has completed, run by Boston Children's Hospital. The registered enrollment target is 288 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02995759 has completed, sponsored by Boston Children's Hospital.

COMPLETED
Registry status
288 participants
Enrollment target

Study Summary

Data strongly suggests that aggressive and early treatment of status epilepticus (SE) is crucial for seizure abortion and prevention of long-term neurologic sequelae. We propose the creation of a seizure action plan, an intervention aimed to guide daily medication use, outline pre-hospital seizure first aid and rescue medication use, and direct emergency personnel in patients' individualized SE medication algorithm, with implementation through the electronic medical record. We hypothesize that the seizure action plan will promote daily medication adherence, increase use of home rescue mediation, and improve timeliness of AED (antiepileptic drug) delivery, length of hospital stay, and ICU admission rate in episodes of status epilepticus.

Primary Outcome

Time from seizure onset to administration of AED

Interventions

  • OTHER Seizure Action Plan

Trial Details

FieldValue
Enrollment Target 288 participants
Start Date 2015-06
Est. Completion 2019-04-30
Boston Children's Hospital

462 total trials

What the finished NCT02995759 record still lists

NCT02995759 is an observational study that tracks outcomes without assigning an intervention. The registered 288 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 1 intervention - of which Seizure Action Plan is the first listed.

NCT02995759 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02995759 about?

NCT02995759 is a clinical study titled "Creation, Implementation, and Analysis of a Seizure Action Plan". Data strongly suggests that aggressive and early treatment of status epilepticus (SE) is crucial for seizure abortion and prevention of long-term neurologic sequelae. We propose the creation of a seizure action plan, an intervention aimed to guide daily medication use, outline pre-hospital seizure f...

What is the current status of trial NCT02995759?

This trial is currently completed. The enrollment target is 288 participants. The study started on 2015-06. Estimated completion is 2019-04-30.

What interventions are being tested in trial NCT02995759?

The interventions under investigation include: Seizure Action Plan (OTHER).

Who is sponsoring clinical trial NCT02995759?

This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02098265 · 288 participants · NA

    A Closed Loop Neural Activity Triggered Stroke Rehabilitation Device

  • NCT03741777 · 288 participants · NA

    Comparison of Residual Gastric Volume Between Children Who Drink Different Clear Oral Fluid Volume

  • NCT03937635 · 288 participants · Phase 3

    Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma

  • NCT04621877 · 288 participants · NA

    Lay-Delivered Behavioral Activation in Senior Centers

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02995759, the US trial registry maintained by the National Library of Medicine. NCT02995759 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.